Hewlett WA, Vinogradov S, Agras WS (1992), Clomipramine(Drug information on clomipramine), clonazepam(Drug information on clonazepam), and clonidine(Drug information on clonidine) treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 12(6):420-430.
Hollander E, Baldini Rossi N, Sood E, Pallanti S (2003a), Risperidone(Drug information on risperidone) augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol 6(4):397-401.
Hollander E, Friedberg J, Wasserman S et al. (2003b), Venlafaxine in treatment-resistant obsessive-compulsive disorder. [Published erratum J Clin Psychiatry 64(8):972.] J Clin Psychiatry 64(5):546-550.
Hollander E, Kaplan A, Stahl SM (2003c), A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. World J Biol Psychiatry 4(1):30-34.
Jenike MA, Baer L, Minichiello WE et al. (1997), Placebo-controlled trial of fluoxetine(Drug information on fluoxetine) and phenelzine(Drug information on phenelzine) for obsessive-compulsive disorder. Am J Psychiatry 154(9):1261-1264 [see comment].
Jenike MA, Rauch SL (1994), Managing the patient with treatment-resistant obsessive-compulsive disorder: current strategies. J Clin Psychiatry 55(suppl):11-17 [see comment].
McDougle CJ, Epperson CN, Pelton GH et al. (2000), A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 57(8):794-801 [see comment].
McDougle CJ, Goodman WK, Leckman JF et al. (1993), Limited therapeutic effect of addition of buspirone(Drug information on buspirone) in fluvoxamine(Drug information on fluvoxamine)-refractory obsessive-compulsive disorder. Am J Psychiatry 150(4):647-649.
